2020
DOI: 10.1016/j.idcr.2020.e00928
|View full text |Cite
|
Sign up to set email alerts
|

Scedosporium apiospermum fungemia successfully treated with voriconazole and terbinafine

Abstract: Scedosporium apiospermum is ubiquitous in the environment and is considered an emerging infection. Immunocompromised hosts can have a wide spectrum of diseases ranging from cutaneous to disseminated disease that may involve pulmonary, central nervous system, or bone. Disseminated disease in immunocompetent hosts is uncommon. Treatment of deep-seated infections is challenging because of the limited susceptibility of the Scedosporium species to all current antifungal drugs. We r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…Further, S apiospermum has intrinsic resistance to amphotericin B making voriconazole the first-line treatment [ 8 ]. While multiple studies have shown success with voriconazole as monotherapy, there is increasing evidence for the use of a combination of voriconazole and terbinafine [ 19 ]. Other successful combinations include triple therapies with voriconazole/caspofungin/amphotericin B [ 20 ] and voriconazole/micafungin/granulocyte-macrophage colony-stimulating factor (GM-CSF) [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Further, S apiospermum has intrinsic resistance to amphotericin B making voriconazole the first-line treatment [ 8 ]. While multiple studies have shown success with voriconazole as monotherapy, there is increasing evidence for the use of a combination of voriconazole and terbinafine [ 19 ]. Other successful combinations include triple therapies with voriconazole/caspofungin/amphotericin B [ 20 ] and voriconazole/micafungin/granulocyte-macrophage colony-stimulating factor (GM-CSF) [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…Further, S apiospermum has intrinsic resistance to amphotericin B making voriconazole the first-line treatment [8]. While multiple studies have shown success with voriconazole as monotherapy, there is increasing evidence for the use of a combination of voriconazole and terbinafine [19].…”
Section: Discussionmentioning
confidence: 99%
“…[ 12 , 15 ], until now, there has few convincing evidence that terbinafine can control fruit postharvest disease in vivo. In the view of the application and safety of terbinafine in human health [ 16 , 17 ], this study was evaluated the potential antifungal activity of terbinafine against B. cinerea in vivo, and expected to provide a potential beneficial antifungal approach for the control of postharvest diseases in fruit products.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the potential additive or synergistic effects, several combinations (such as voriconazole plus terbinafine, miconazole plus itraconazole) showed successful outcomes in S. apiospermum infection based on case reports. 34 , 35 Overall, with the expansion of the antifungal armamentarium, the treatment of S. apiospermum may be easier with novel antifungal agents or combination strategies.…”
Section: Discussionmentioning
confidence: 99%